Intu Diagnostics
Summary active Updated Jun 28, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
Intu Diagnostics is a Leipzig-based diagnostics spin-off from the Fraunhofer Society, building a decentralised molecular diagnostics platform designed to make high-quality infectious disease testing accessible beyond centralised laboratory environments 12. The company’s all-in-one cartridge detects pathogenic genetic material using PCR-equivalent methodology without requiring laboratory equipment, power sources, or specialised training — users collect a sample, place it in the cartridge, and check for a colour change within 30 minutes 1. The platform’s first application is cervical cancer screening via HPV detection, with planned expansion to respiratory viruses, sexually transmitted infections, malaria, and tuberculosis 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-06-26 | Bridge | €1.1M | BSV Ventures | Saxonian Development Bank (SAB), business angels 123 |
The bridge round brings Intu Diagnostics’ total funding to over €3 million, with proceeds going toward strengthening its IP position, conducting pilot manufacturing trials, and preparing for a planned Seed round 123. The company plans a consumer launch in 2027 1.
What Investors Say
No independently sourced investor quotes incorporated at this time.
What Founders Say
“The clinical laboratory is expanding. It no longer requires a physical facility, a power grid, or a centralised destination. At INTU Diagnostics, we are introducing the concept of ‘LAB-TO-GO’ — bringing a doctor’s office level of reliability straight to the patient’s door with a pocket-sized, power-free platform.”
— Intu Diagnostics company statement 2
Sources
-
TechFundingNews, “German spinout raises over €3M to tackle cervical cancer with a test that works anywhere without electricity or a lab,” June 26, 2026. Accessed June 2026. https://techfundingnews.com/intu-diagnostics-1-1m-lab-free-hpv-testing/↩↩↩↩↩↩
-
BeBeez International, “Lab-free testing moves closer to home as Germany’s Intu Diagnostics raises €1.1 million,” June 26, 2026. Accessed June 2026. https://bebeez.eu/2026/06/26/lab-free-testing-moves-closer-to-home-as-germanys-intu-diagnostics-raises-e1-1-million/↩↩↩↩
-
EU-Startups, “Lab-free testing moves closer to home as Germany’s Intu Diagnostics raises €1.1 million,” June 2026. Accessed June 2026. https://www.eu-startups.com/2026/06/lab-free-testing-moves-closer-to-home-as-germanys-intu-diagnostics-raises-e1-1-million↩↩